Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Study Evaluating the Efficacy and Safety of CLS2901C in Patients With Osteoarthritis of the Knee

NCT06549686 is registered in ClinicalTrials.gov with CellSeed Inc. as lead sponsor.

NCT NCT06549686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06549686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Study Evaluating the Efficacy and Safety of CLS2901C in Patients With Osteoarthritis of the Knee
Lead sponsor
CellSeed Inc.
Phase
Phase 3
Overall status
Recruiting
Start date
October 20, 2023
Completion date
July 31, 2031
Enrollment
96 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis of the knee